Wells Fargo upgraded Abbott Labs (NYSE: ABT) from Market Perform to Outperform with a price target of $71 to $74 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE